Gut microbiota modulation of chemotherapy efficacy and toxicity. (Q36300217)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

title

Gut microbiota modulation of chemotherapy efficacy and toxicity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

Julian R Marchesi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

James M. Kinross

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

5

Jeremy K Nicholson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

author name string

James L Alexander

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

Ian D Wilson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

language of work or name

English

0 references

publication date

8 March 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

Nature Reviews Gastroenterology & Hepatology

4 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

page(s)

356-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

cites work

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

30-day mortality after systemic anticancer treatment for breast and lung cancer in England: a population-based, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Intra-tumour heterogeneity: a looking glass for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Cancer drugs in the United States: Justum Pretium--the just price

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Patterns of onset and resolution of immune-related adverse events of special interest with ipilimumab: detailed safety analysis from a phase 3 trial in patients with advanced melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Resistance to combination BRAF and MEK inhibition in metastatic melanoma: Where to next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Global systems biology, personalized medicine and molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The gut microbiota and host health: a new clinical frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Gut microorganisms, mammalian metabolism and personalized health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The influence of gut microbiota on drug metabolism and toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Drug metabolism by intestinal microorganisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Urinary excretion of reduced metabolites of digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Composition, variability, and temporal stability of the intestinal microbiota of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Leukemia and risk of recurrent Escherichia coli bacteremia: genotyping implicates E. coli translocation from the colon to the bloodstream.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Translocation of microorganisms across the intestinal wall of the rat: effect of microbial size and concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Immunogenic cell death in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

TLR signaling modulates side effects of anticancer therapy in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Review of therapeutic drug monitoring of anticancer drugs part 1--cytotoxics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Mucositis: pathobiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Updated clinical practice guidelines for the prevention and treatment of mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Irinotecan in the treatment of colorectal cancer: clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The Inhibitory Effect of Ciprofloxacin on the β-Glucuronidase-mediated Deconjugation of the Irinotecan Metabolite SN-38-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Old drug new use--amoxapine and its metabolites as potent bacterial β-glucuronidase inhibitors for alleviating cancer drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Sorivudine and 5-fluorouracil; a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The cytostatic activity of pyrimidine nucleosides is strongly modulated by Mycoplasma hyorhinis infection: Implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

16S rRNA gene pyrosequencing reveals shift in patient faecal microbiota during high-dose chemotherapy as conditioning regimen for bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Chemotherapy-driven dysbiosis in the intestinal microbiome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Metabolic phenotyping in clinical and surgical environments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Pretreatment gut microbiome predicts chemotherapy-related bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fat, fibre and cancer risk in African Americans and rural Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fasting and Caloric Restriction in Cancer Prevention and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Synergic chemoprevention with dietary carbohydrate restriction and supplementation of AMPK-activating phytochemicals: the role of SIRT1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fasting Reduces the Incidence of Delayed-Type Vomiting Associated with Doxorubicin Treatment in Dogs with Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fasting protects against the side effects of irinotecan but preserves its anti-tumor effect in Apc15lox mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Panax ginseng--a non-organ-specific cancer preventive?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Protopanaxadiol, an active ginseng metabolite, significantly enhances the effects of fluorouracil on colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Description of urolithin production capacity from ellagic acid of two human intestinal Gordonibacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The efficacy and safety of probiotics in people with cancer: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Randomized study of the effect of synbiotics during neoadjuvant chemotherapy on adverse events in esophageal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Nontoxic potentiation of cancer chemotherapy by dietary oligofructose or inulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

An inulin and doxorubicin conjugate for improving cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Lateral gene transfer and the nature of bacterial innovation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fecal microbiota transplantation and emerging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fecal microbiota transplantation--an old therapy comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Policy: How to regulate faecal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

E. coli-produced BMP-2 as a chemopreventive strategy for colon cancer: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Synchronized cycles of bacterial lysis for in vivo delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Preparing for Precision Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Gut microbiota: a potential new territory for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Bacterial Translocation Is Reduced by a Specific Nutritional Combination in Mice with Chemotherapy-Induced Neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Antitumour immunity gets a boost

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Cyclophosphamide induces differentiation of Th17 cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Mycoplasma infections and different human carcinomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Tyrosine and phenylalanine restriction induces g0/g1 cell cycle arrest in murine melanomain vitroandin vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Probiotic effects on 5-fluorouracil-induced mucositis assessed by the sucrose breath test in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Seres's pioneering microbiome drug fails mid-stage trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRGASTRO.2017.20

Enhanced TLR4 Expression on Colon Cancer Cells After Chemotherapy Promotes Cell Survival and Epithelial-Mesenchymal Transition Through Phosphorylation of GSK3β.

31 March 2020

1 reference

12 December 2020

Tumor heterogeneity: causes and consequences

1 reference

12 December 2020

The Treatment of Inoperable Sarcoma by Bacterial Toxins (the Mixed Toxins of the Streptococcus erysipelas and the Bacillus prodigiosus).

1 reference

12 December 2020

Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis - current evidence and potential clinical applications

1 reference

12 December 2020

Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma

1 reference

12 December 2020

Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea

1 reference

12 December 2020

Methionine deprivation suppresses triple-negative breast cancer metastasis in vitro and in vivo

1 reference

12 December 2020

Possible adjuvant cancer therapy by two prebiotics--inulin or oligofructose.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRGASTRO.2017.20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28270698 AND SRC:MED&resulttype=core&format=json

4 April 2020

1 reference